Nuzenio

Obesity Trial

Obesity Trial news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 14 latest news signals 10 publisher sources 100/100 entity strength

Latest news

Biophytis (BPTSY) wins ANVISA approval for multi-regional BIO101 obesity trial - Stock TitanStock Titan · Mon, 10 Aug 2026 21:18:40 GMTNeurocrine begins Phase I trial of NBIP-‘1968 triple agonist for obesity - Clinical Trials ArenaClinical Trials Arena · Mon, 10 Aug 2026 13:34:39 GMTChild Obesity study co-led by Pennington Biomedical in Baton Rouge shows promising results - WBRZWBRZ · Mon, 10 Aug 2026 11:25:16 GMTVeru completes enrollment of obesity drug trial with 239 patients - Investing.comInvesting.com · Mon, 10 Aug 2026 11:00:40 GMTOral Weight Loss Pill Helps Patients Lose up to 12% of Body Weight - SciTechDailySciTechDaily · Fri, 07 Aug 2026 18:12:52 GMTNeurocrine advances GLP-1/GIP/glucagon triple agonist into first-in-human obesity study - AllSciAllSci · Fri, 07 Aug 2026 16:26:00 GMTEli Lilly offers new weight loss drug to some patients before FDA approval - LiveNOW from FOXLiveNOW from FOX · Fri, 07 Aug 2026 15:20:40 GMTNeurocrine starts Phase 1 trial for new obesity drug NBIP-'1968 targeting multiple metabolic pathways. - PluangPluang · Fri, 07 Aug 2026 12:49:32 GMT

Timeline

Mon, 10 Aug 2026 21:18:40 GMTBiophytis (BPTSY) wins ANVISA approval for multi-regional BIO101 obesity trial - Stock Titan
Mon, 10 Aug 2026 13:34:39 GMTNeurocrine begins Phase I trial of NBIP-‘1968 triple agonist for obesity - Clinical Trials Arena
Mon, 10 Aug 2026 11:25:16 GMTChild Obesity study co-led by Pennington Biomedical in Baton Rouge shows promising results - WBRZ
Mon, 10 Aug 2026 11:00:40 GMTVeru completes enrollment of obesity drug trial with 239 patients - Investing.com
Fri, 07 Aug 2026 18:12:52 GMTOral Weight Loss Pill Helps Patients Lose up to 12% of Body Weight - SciTechDaily
Fri, 07 Aug 2026 16:26:00 GMTNeurocrine advances GLP-1/GIP/glucagon triple agonist into first-in-human obesity study - AllSci

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Obesity Trial.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.